Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
USRE46453E1 · kind E1 · reissue
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 25, 2015 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Feb 25, 2035 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to a fusion protein comprising a fusion polypeptide of E6 and E7 of a human papilloma virus, a signal peptide for secreting the polypeptide out of the cell, and an immune enhancing peptide for a subject; a polynucleotide encoding the fusion protein; and a vector containing the polynucleotide. The present invention further relates to a pharmaceutical composition comprising the fusion protein or the vector; and a method for treating a disease caused by a human papilloma virus using the pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.